INDIA EDITION
--- VIEWS

NATCO Pharma launches generic blood cancer treatment medicine in U.S.

TLN
NATCO Pharma launches generic blood cancer treatment medicine in U.S.
The product is available in 1mg, 2mg, 3mg, and 4mg strengths and is distributed primarily through specialty pharmacies and clinics, NATCO Pharma said

Reporting by The Hindu.

Read Original Story
Share this story

Reader Reactions
Reader Comments
No comments yet. Be the first to comment!
Post a Comment